The application of lipid peroxidation inhibitors (liproxstatin-1 and ferrostatin-1) and iron chelators (deferasirox and deferoxamine/DFO) successfully rescued MLX-silenced osteosarcoma cells (Fig. 4I), verifying that knockdown of MLX could result in ferroptosis. This evidence concerns the gene MLX and osteosarcoma.